Tesco identifies sites of first U.S. stores
LOS ANGELES Tesco has identified the six Southern California cities where it will open its first U.S. stores on Nov. 8. The British grocer will open Fresh & Easy stores in Anaheim, West Covina, Hemet, Upland, Arcadia and the Glassell Park section of Los Angeles.
The stores will employ more than 170 people with 40 percent of those full-time workers.
Tesco plans to open up to 30 of the 10,000-square-foot markets by the end of the year including stores in Las Vegas, Phoenix and San Diego. Long-term plans call for up to 350 openings over the next four years.
IRI hosts town meetng for Wal-Mart suppliers
CHICAGO Information Resources Inc. is a hosting a Wal-Mart Supplier Town Hall Meeting to show the latest innovations in product assortment and space planning solutions to help suppliers grow their business with Wal-Mart.
IRI will address its partnership with Bentonville Software Associates that will align the customer data and space planning processes that use each company’s software. Wal-Mart relies on these companies to help their suppliers improve category performance and reduce internal labor costs. The software from the companies also streamlines data integration, sales forecasting, as well as evaluates profitability and out of stocks.
The meeting will take place on Oct. 30th in Rogers, Ariz. From 8-11:30 a.m. CST.
Educational children’s book about hemophilia published by Bayer and BioRx
CINCINNATI Bayer HealthCare and BioRx, a specialty pharmaceutical company, have joined together to publish a children’s book about hemophilia.
Written by Chris Perretti Barnes, the mother of a young boy with hemophilia A, I AM NATE is the second in a series of books intended to educate children about hemophilia.
“For children living with hemophilia, learning and talking about hemophilia and inhibitors can be overwhelming, confusing, and scary,” said Barnes. “I AM NATE can help parents open up lines of communication with their child and begin a discussion in a friendly, fun, and safe way. It is wonderful that both Bayer and BioRx value educating youth in the hemophilia community.”
Hemophilia is an inherited blood disorder characterized by prolonged or spontaneous bleeding, especially into the muscles, joints or internal organs that effects about 17,000 Americans. Deficient or defective blood coagulation proteins, known as factor VIII or IX, cause the disease. The most common form of the disease is hemophilia A, or classic hemophilia, in which the clotting factor VIII is either deficient or defective. Hemophilia B is characterized by deficient or defective factor IX.